Related Experiment Video
Updated: Jun 1, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Rational use of human albumin: plan-do-check-act cycle in clinical practice
Xiaowei Huang1, Xuehui Jiang1, Fangfang Xiong2
1Department of Pharmacy, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, Fujian, China.
Insights
The plan-do-check-act (PDCA) cycle significantly improved human albumin (HA) use in hospitals. This quality improvement strategy increased rational HA prescription rates and optimized patient care.
Area of Science:
- Clinical Medicine
- Healthcare Management
- Quality Improvement
Background:
- Improper use of human albumin (HA) is a prevalent issue in clinical practice.
- Ensuring rational HA administration is crucial for patient outcomes and resource management.
Purpose of the Study:
- To evaluate the feasibility and effectiveness of the plan-do-check-act (PDCA) cycle in promoting the rational use of human albumin.
- To assess the impact of a PDCA intervention on HA prescription patterns and patient care.
Main Methods:
- A before-and-after control study design was employed.
- The study compared a control group with an observation group that underwent the PDCA cycle.
- Key metrics analyzed included serum albumin detection rates, HA usage, and prescription rationality.
Main Results:
- The PDCA cycle intervention led to a significant increase in the rational use of HA, with prescription rates rising from 68.3% to 96.2%.
- Serum albumin detection rates before HA application improved from 83.9% to 98.9%.
- The median amount of HA used decreased by 20g, and the duration of use was shortened by 2 days, indicating more efficient utilization.
Conclusions:
- The plan-do-check-act (PDCA) cycle is an effective strategy for promoting the rational use of human albumin in clinical settings.
- Implementing PDCA cycles can lead to improved healthcare quality and resource optimization.
Objective:
Improper use of human albumin (HA) is now common in clinical settings. This study aims to explore the feasibility of the plan-do-check-act (PDCA) cycle in promoting the rational use of HA.
Methods:
The differences between the control and observation groups (after the PDCA cycle) in terms of serum albumin detection rate, serum albumin values, HA usage, and rationality were analysed and compared using a before-and-after control method.
Results:
A total of 372 patients were recruited, including 186 in each of the control and observation groups. On comparison, it was observed that the overall use of HA improved after the PDCA cycle compared with the preintervention period, and the rational rate of HA prescriptions increased from 68.3% to 96.2%. The serum albumin detection rate before applying for HA increased from 83.9% to 98.9%, and the median values decreased from 26.7 (22.8-30.9) g/L to 24.7 (22.7-27.2) g/L. Regarding the use of HA, the median amount of HA used was reduced by 20 g compared with the preintervention period, meanwhile, the median duration was shortened by 2 days.
Conclusion:
The PDCA cycle is desirable when employed to promote the rational use of HA.
Related Concept Videos
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
Drug Distribution: Plasma Protein Binding
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Errors occurring during blood pressure monitoring
Several factors...

